Spastic syndrome
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Petechiae
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Asymptomatic human immunodeficiency virus infection
|
disease |
Infections; Immune System Diseases
|
Disease or Syndrome
|
26
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Serous Tubal Intraepithelial Carcinoma
|
disease |
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Metastatic human epidermal growth factor 2 positive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
42
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Petechiae of skin
|
phenotype |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Sign or Symptom
|
54
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Febrile Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
58
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
High grade serous carcinoma
|
disease |
|
Neoplastic Process
|
118
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Fibromyalgia
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
143
|
38
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Epstein-Barr Virus Infections
|
group |
Infections
|
Disease or Syndrome
|
384
|
72
|
0.040 |
None |
1.000 |
4 |
|
1989 |
2004 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
T-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
485
|
24
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Migraine Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
512
|
264
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Diarrhea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
632
|
63
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Immunosuppression
|
disease |
|
Disease or Syndrome
|
632
|
9
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Herpes Simplex Infections
|
group |
Infections; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
645
|
11
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Fatigue
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
760
|
67
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
HIV Infections
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
807
|
142
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
847
|
94
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hepatocarcinogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
855
|
24
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
919
|
110
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |